DEXAMETHASONE PO4 / MOXIFLOXACIN HCL / BROMFENAC SODIUM SESQUIHYDRATE 0.1% / 0.5% / 0.007% OMNI BY OCULAR SCIENCE - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
87826220
Word Mark
DEXAMETHASONE PO4 / MOXIFLOXACIN HCL / BROMFENAC SODIUM SESQUIHYDRATE 0.1% / 0.5% / 0.007% OMNI BY OCULAR SCIENCE
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2019-05-20
Filing Date
2018-03-08
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
260121, 261701, 261706, 261709 - Circles that are totally or partially shaded. Straight line(s), band(s) or bar(s). Diagonal line(s), band(s) or bar(s). Curved line(s), band(s) or bar(s).
Published for Opposition Date
2018-08-21
Attorney Name
Law Office Assigned Location Code
N30
Employee Name
BEDNARZ, DUSTIN THOMAS
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"DEXAMETHASONE PO4 / MOXIFLOXACIN HCL / BROMFENAC SODIUM SESQUIHYDRATE 0.1% / 0.5% / 0.007%" AND "OCULAR SCIENCE"
Description of Mark
The mark consists of the words "Dexamethasone PO4 / Moxifloxacin HCl / Bromfenac Sodium Sesquihydrate 0.1% / 0.5% / 0.007%" above the words of "OMNI by OCULAR SCIENCE". The "Dexamethasone PO4 /" words are above the "Moxifloxacin HCl / Bromfenac" words. The "Moxifloxacin HCl / Bromfenac" words are above the "Sodium Sesquihydrate" words. The "Sodium Sesquihydrate" words are above the "0.1% / 0.5% / 0.007%" words. The "Bromfenac Sodium Sesquihydrate 0.1% / 0.5% / 0.007%" words are superimposed over a background of stripes. The word "OMNI" is above the words "by OCULAR SCIENCE". The words "by OCULAR SCIENCE" is centered with respect to "OMNI". The lettering for "OMNI" is larger than the lettering for "by OCULAR SCIENCE". There is a shaded circle behind most of the letter "M" in "OMNI". There is a top arc that begins between the "O" and the "M" of "OMNI" and arcs towards the right ending to the right of the "I" in "OMNI". There is a bottom arc that begins at the "N" in "OMNI" and then arcs towards the left ending to the left of the "O" in "OMNI".
Goods and Services
Ophthalmic preparations
Pseudo Mark
DEXAMETHASONE PHOSPHATE / MOXIFLOXACIN HYDROCHLORIC ACID/ BROMFENAC SODIUM SESQUIHYDRATE ONE TENTH PERCENT / 5 TENTHS PERCENT / 7 THOUSANDTHS PERCENT OMNI BY OCULAR SCIENCE
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-03-15
Primary Code
005
Correspondences
Name
ERIC KELLY
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2018-03-12 | NEW APPLICATION ENTERED IN TRAM |
2018-03-15 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-03-16 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2018-06-20 | ASSIGNED TO EXAMINER |
2018-06-27 | EXAMINERS AMENDMENT -WRITTEN |
2018-06-27 | EXAMINERS AMENDMENT E-MAILED |
2018-06-27 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2018-06-27 | EXAMINER'S AMENDMENT ENTERED |
2018-07-02 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2018-07-16 | ASSIGNED TO LIE |
2018-08-01 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2018-08-21 | PUBLISHED FOR OPPOSITION |
2018-08-21 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2018-10-16 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2019-05-20 | ABANDONMENT - NO USE STATEMENT FILED |
2019-05-20 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |